Evidence map›Paper›PMID 33549587›Full record

ArticleJournal of molecular biology2021

Active and Passive Destabilization of G-Quadruplex DNA by the Telomere POT1-TPP1 Complex.

Mengyuan Xu, Armend Axhemi, Magdalena Malgowska, Yinghua Chen, Daniel Leonard, Sukanya Srinivasan, Eckhard Jankowsky, Derek J Taylor

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. G-quadruplex DNA: a novel target for drug design.Cellular and molecular life sciences : CMLS · 2021
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mengyuan XuDepartment of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, USA.
Armend AxhemiCenter for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, OH 44106, USA; Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA.
Magdalena MalgowskaDepartment of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, USA.
Yinghua ChenThe Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH 44106, USA.
Daniel LeonardDepartment of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
Sukanya SrinivasanCenter for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, OH 44106, USA; Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA.
Eckhard JankowskyCenter for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, OH 44106, USA; Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA. Electronic address: exj13@case.edu.
Derek J TaylorDepartment of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, USA; Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA. Electronic address: djt36@case.edu.
Case Western Reserve University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Enzymes and enzyme complexes in RNA metabolismR35GM118088 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI JANKOWSKY, ECKHARD · 2016 to 2022
$4.3M
Structural and molecular determinants of protein phosphatase 2A in Alzheimer's DiseaseR01CA240993 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NARLA, GOUTHAM, TAYLOR, DEREK JAMES · 2019 to 2023
$3.4M
Molecular interactions and regulatory events of telomere proteinsR01GM133841 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI TAYLOR, DEREK JAMES · 2019 to 2022
$1.7M
NCI NIH HHS R01 CA240993NIGMS NIH HHS R01 GM133841NIGMS NIH HHS R35 GM118088NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Chromosome ends are protected by guanosine-rich telomere DNA that forms stable G-quadruplex (G4) structures. The heterodimeric POT1-TPP1 complex interacts specifically with telomere DNA to shield it from illicit DNA damage repair and to resolve secondary structure that impedes telomere extension. The mechanism by which POT1-TPP1 accomplishes these tasks is poorly understood. Here, we establish the kinetic framework for POT1-TPP1 binding and unfolding of telomere G4 DNA. Our data identify two modes of POT1-TPP1 destabilization of G4 DNA that are governed by protein concentration. At low concentrations, POT1-TPP1 passively captures transiently unfolded G4s. At higher concentrations, POT1-TPP1 proteins bind to G4s to actively destabilize the DNA structures. Cancer-associated POT1-TPP1 mutations impair multiple reaction steps in this process, resulting in less efficient destabilization of G4 structures. The mechanistic insight highlights the importance of cell cycle dependent expression and localization of the POT1-TPP1 complex and distinguishes diverse functions of this complex in telomere maintenance.

Indexed as

G-QuadruplexesAminopeptidasesHumansMultiprotein ComplexesMutationProtein BindingProtein ConformationProtein Structure, SecondarySerine ProteasesShelterin ComplexTelomeraseTelomereTelomere-Binding ProteinsACD protein, humanAminopeptidasesMultiprotein ComplexesPOT1 protein, humanSerine ProteasesShelterin ComplexTelomeraseTelomere-Binding ProteinsDNA topologyenergy landscapeG4kinetics

Identifiers

PMID33549587
PMCPMC8020995
OpenAlexW3127355498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.